299660 셀리드

기본 정보

  • 섹터: KOSDAQ:일반서비스
  • 시가총액: 414억원 (2026-06-30 기준)
  • 첫 등장: 2026-06-26 (누적 1일)
  • 태그: 매크로/바이오헬스 · 항암백신 · 면역치료 · CDMO · 바이오벤처 · 아데노바이러스벡터
  • 네이버 금융: 🔗

기업개요

  • 동사는 2006년 항암면역치료백신 및 COVID-19 예방백신 개발 전문 바이오벤처로 설립되어 2019년 코스닥에 상장함.
  • CeliVax를 기반으로 항암면역치료백신과 아데노바이러스 벡터 기반 COVID-19 백신을 개발 중이고, 2020년 완공한 GMP시설로 CMO/CDMO 사업을 전개하고 있음.
  • 2024년 포베이커를 소규모 합병하여 이커머스 사업부를 신설, 베이킹재료, 소모품, 기자재 등 온라인 식품 유통 판매업을 하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자전일 종가종가등락률시간외vol색깔smart금투그외
2026-07-141,1551,121🔵 -2.94%×0.6🟢 외인+1.1억+1.1+0.0+0.0+0.0-1.1+0.0
2026-07-131,2551,155🔵 -7.97%×0.7🟢 외인+0.5억+0.5+0.0+0.0+0.0-0.5+0.0
2026-07-101,2751,255🔵 -1.57%×0.8🔻 개인-0.9억-0.9+0.0-0.0+0.0+0.9+0.0
2026-07-091,3451,275🔵 -5.20%×0.6🔻 개인-0.3억-0.3+0.0+0.0+0.0+0.3-0.1
2026-07-081,4171,345🔵 -5.08%×0.6🔻 개인-0.8억-0.8+0.0+0.0+0.0+0.7+0.1
2026-07-071,4301,417🔵 -0.91%×0.4🟢 외인+0.1억+0.1+0.0+0.0+0.0-0.1+0.0
2026-07-061,4431,430🔵 -0.90%×0.4🔻 개인-0.4억-0.4+0.0+0.0+0.0+0.3+0.1
2026-07-031,4271,443🔴 +1.12%×0.6🟢 외인+0.7억+0.7+0.0+0.0+0.0-0.6-0.1
2026-07-021,5341,427🔵 -6.98%×0.7🔻 개인-1.0억-1.0+0.0+0.0+0.0+1.1-0.1
2026-07-011,4061,534🔴 +9.10%×2.8🟢 외인+5.0억+5.0+0.0+0.0+0.0-5.2+0.3
2026-06-301,9501,406🔵 -27.90%×10.5🔻 개인-0.8억-0.8+0.0+0.0+0.0+0.6+0.2
2026-06-292,7851,950🔵 -29.98%×0.9⚫ 그외+0.0억+0.0+0.0+0.0+0.0-0.1+0.1
2026-06-262,4302,785🔴 +14.61%×2.2🔻 개인-0.1억-0.1+0.0+0.0+0.0+0.0+0.0
2026-06-252,4302,430⚪ +0.00%×0.6🔻 개인-0.2억-0.2+0.0+0.0+0.0+0.2+0.0
2026-06-242,4002,430🔴 +1.25%×0.7🔻 개인-0.8억-0.8+0.0+0.0+0.0+0.8+0.0
2026-06-232,6752,400🔵 -10.28%×1.2🟢 외인+0.2억+0.2+0.0+0.0-0.2-0.0
2026-06-222,7602,675🔵 -3.08%×1.0🔻 개인-0.7억-0.7+0.0+0.0+0.7+0.0
2026-06-192,6202,760🔴 +5.34%×3.5🔻 개인-3.3억-3.3+0.0+0.0+3.3+0.0
2026-06-182,7052,620🔵 -3.14%×0.7🔻 개인-0.9억-0.9+0.0+0.0+0.9+0.0
2026-06-172,4702,705🔴 +9.51%×1.6🟢 외인+3.3억+3.3+0.0-2.2-1.1+0.0
2026-06-162,4802,470🔵 -0.40%×0.4🔻 개인-0.3억-0.3+0.0+0.0+0.3+0.0
2026-06-152,5352,480🔵 -2.17%×0.5🔻 개인-1.0억-1.0+0.0+0.0+1.0+0.0
2026-06-122,3952,535🔴 +5.85%×0.5🔻 개인-0.7억-0.7+0.0+0.0+0.7+0.0
2026-06-112,3902,395🔴 +0.21%×0.5🔻 개인-0.1억-0.1+0.0+0.0+0.1+0.0
2026-06-102,4902,390🔵 -4.02%×0.6🟢 외인+0.6억+0.6+0.0+0.0-0.6+0.0
2026-06-092,5452,490🔵 -2.16%×0.6🔻 개인-1.3억-1.3+0.0+0.0+1.3+0.0
2026-06-082,7652,545🔵 -7.96%×0.7🟢 외인+2.2억+2.2+0.0-0.0-2.2+0.0
2026-06-052,8552,765🔵 -3.15%×0.2🔻 개인-0.1억-0.1+0.0+0.0+0.1-0.0
2026-06-042,8002,855🔴 +1.96%×0.2🟢 외인+0.4억+0.4+0.0+0.0-0.4-0.1
2026-06-022,7752,800🔴 +0.90%×0.3⚫ 그외-0.0억-0.0+0.0+0.0-0.1+0.1
2026-06-013,0002,775🔵 -7.50%×0.7🟢 외인+0.3억+0.3+0.0-0.0-0.4+0.1
2026-05-293,0353,000🔵 -1.15%×0.2🔻 개인-0.4억-0.4+0.0+0.0+0.4+0.0
2026-05-283,2803,035🔵 -7.47%×0.3🔻 개인-2.1억-2.1+0.0+0.0+2.0+0.0
2026-05-273,3503,280🔵 -2.09%×0.7🟢 외인+0.1억+0.1+0.0+0.0+0.0-0.1
2026-05-263,2653,350🔴 +2.60%×0.4🟢 외인+0.5억+0.5+0.0+0.0-0.3-0.1
2026-05-223,0503,265🔴 +7.05%×0.3🟢 외인+2.8억+2.8+0.0+0.0-3.0+0.2

일자별 사유 (최신 위)

2026-06-26

  • 사유: 코로나 백신 AdCLD-CoV19-1 OMI 3상 결과 공시 + 신규변이 수혜
  • 섹터 컨텍스트: KOSDAQ:일반서비스 (smart -747억)
  • 매크로 원인: 셀리드 코로나19 백신 3상 임상결과 공시 + 신규변이 BA.3.2.2 면역회피 이슈로 코로나 백신주 부각 (높음)